Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02302261 · ClinicalTrials.gov registry record

Pleth Variability and Asthma Severity in Children

A clinical trial of Status Asthmaticus, sponsored by Northwell Health.

Completed
Registry status
37
Enrollment target
1
Study location

NCT02302261 is a study of Status Asthmaticus that has completed, run by Northwell Health. The registered enrollment target is 37 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02302261, a study of Status Asthmaticus, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
37 participants
Enrollment target
1
Study location

Study Summary

Research has shown that pleth variability can be used to assess asthma severity in children with status asthmaticus. The investigators would like to use an FDA-cleared monitor (Masimo Radical 7) which measures Pleth Variability Index (PVI) to see if the degree of PVI can be used to help triage patients who present to the pediatric ED in status asthmaticus.

Conditions Studied

Study Locations (1)

New York

  • Cohen Children's Medical Center of NY - New Hyde Park

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2015-01
Est. Completion 2016-07

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT02302261

The ClinicalTrials.gov registry entry for NCT02302261 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Status Asthmaticus appearing as the primary indexed condition, and to 0 interventions.

NCT02302261 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02302261 about?

NCT02302261 is a clinical study titled "Pleth Variability and Asthma Severity in Children". Research has shown that pleth variability can be used to assess asthma severity in children with status asthmaticus. The investigators would like to use an FDA-cleared monitor (Masimo Radical 7) which measures Pleth Variability Index (PVI) to see if the degree of PVI can be used to help triage patie...

What is the current status of trial NCT02302261?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2015-01. Estimated completion is 2016-07.

What conditions does trial NCT02302261 study?

This clinical trial studies the following conditions: Status Asthmaticus.

Who is sponsoring clinical trial NCT02302261?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02302261 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Status Asthmaticus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.